Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bufei Jianpi Granule for Early-Stage COPD
NCT03976700Phase 3Unknown
- Sponsor
- Henan University of Chinese Medicine
- Start
- Jun 2019
- Primary completion
- Jun 2021
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Bufei Jianpi granule with Placebo (2 arms). Primary endpoints: Forced Expiratory Volume in 1 second at Week 104 and Frequency of acute exacerbation. Status: unknown.
02
Drugs
bufei fang
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03976700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03976700.